Magazine Article | August 3, 2020

It's Past Time To Retake Control Of America's Drug Supply

Source: Life Science Leader

By Bill Wiederseim

In the not-so-distant past, America was number one in pharmaceutical innovation, manufacturing excellence, and product quality, in large part because U.S. pharmaceutical companies had ultimate control over their supply chains, manufacturing facilities, and packaging operations. Those days are gone.

Today, Asia produces most of the small-molecule APIs used to make generic and branded prescription drugs sold in the U.S. The U.S. drug supply is 90 percent generic, by volume, with some 80 percent of the APIs used to make these generics, as well as branded drugs, coming from China or India.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: